Fractyl Health, Inc.
Income Statement
| Line Item | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0K | $14.0K | $43.0K | $33.0K | $7.0K | $36.0K | $72.0K | $5.0K |
| Cost of Revenue | $0 | $7.0K | $24.0K | $19.0K | $2.0K | $25.0K | $47.0K | $3.0K |
| Gross Profit | $3.0K | $7.0K | $19.0K | $14.0K | $5.0K | $11.0K | $25.0K | $2.0K |
| Gross Margin | 100.0% | 50.0% | 44.2% | 42.4% | 71.4% | 30.6% | 34.7% | 40.0% |
| Operating Expenses | ||||||||
| Research & Development | $20.3M | $19.0M | $16.8M | $14.4M | $10.2M | $9.4M | $9.1M | $9.3M |
| SG&A Expense | $4.9M | $4.8M | $6.2M | $7.1M | $2.8M | $4.5M | $2.8M | $2.8M |
| Operating Income | $-25.2M | $-23.8M | $-23.0M | $-21.5M | $-13.0M | $-13.9M | $-11.9M | $-12.1M |
| Operating Margin | -840,333.3% | -169,957.1% | -53,453.5% | -65,278.8% | -185,442.9% | -38,536.1% | -16,493.1% | -242,140.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-25.0M | $-23.2M | $-17.2M | $-3.3M | $-19.2M | $-15.7M | $-30.2M | $-11.9M |
| Net Margin | -832,333.3% | -165,521.4% | -40,067.4% | -10,066.7% | -274,000.0% | -43,741.7% | -41,988.9% | -238,640.0% |
| EPS (Basic) | $-0.61 | $-0.02 | $-0.02 | $-0.01 | $-0.53 | $-0.46 | $-0.79 | $-0.37 |
| EPS (Diluted) | $-0.61 | $-0.02 | $-0.02 | $-0.01 | $-0.53 | $-0.46 | $-0.79 | $-0.37 |
| Shares Outstanding (Basic) | 43.5M | 1.01B | 1.01B | 624.5M | 43.7M | 43.9M | 43.6M | 43.2M |
| Shares Outstanding (Diluted) | 43.5M | 1.01B | 1.01B | 624.5M | 43.7M | 43.9M | 43.6M | 43.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |